wt-1
Vaccineexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2006 (NCT00398138)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- wt-1
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00665002 | N/A | Jun 1, 2008 | Innovive Pharmaceuticals, University of South Florida |
| NCT00398138 | Phase 1 | Oct 1, 2006 | Cornell University, Innovive Pharmaceuticals, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Innovive Pharmaceuticals | For profit | 2 | 0 | 2 | 2006 |
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2006 |
| University of South Florida | Academic/Hospital | 1 | 1 | 1 | 2008 |
4 organizations
Page 1 / 1